Pieris Pharmaceuticals R&D Day
Pieris Pharmaceuticals’ [PIRS] R&D Day at Convene (530 5th Ave) featuring Sally E Wenzel, Geoffrey Ku, and Michael Curran. Registration and lunch will be served at 12PM and presentations will take place from 12:30-3:30PM. To RSVP, please email email@example.com.
Tuesday, November 19, 2019 | Convene Event Space
12:30 – 3:30 PM | 530 5th Avenue
Michael A. Curran, PhD
MD Anderson’s Associate Professor of Immunology & co-Scientific Director of the Oncology Research for Biologics and Immunotherapy Translation (ORBIT) program that coordinates development and production of clinical immunotherapeutic antibodies. Trained in Dr. Jim Allison’s lab at MSK and earned SITC’s Presidential Award for immunologic studies of 4-1BB agonist antibodies.
Geoffrey Y. Ku, MD
Principal Investigator of PRS-343 Ph 1 Monotherapy study; Medical Oncologist at Memorial Sloan Kettering. PI on multiple studies of HER2+ tumors with clinical expertise of GI malignancies, esophageal and gastric cancers, as well as new chemotherapies.
Anuradha Ray, PhD
Professor of Medicine, Department of Immunology and UPMC Endowed Chair in Lung Immunology Medicine, University of Pittsburgh
Sally E. Wenzel, MD
Professor of Medicine, Chair of the Department of Environmental and Occupational Health, the Director of the University of Pittsburgh Asthma Institute, and a member of the Cellular and Molecular Pathology Graduate Training Program. Global expert in severe asthma and pioneered the concept of asthma phenotypes, including the progression of molecular phenotyping.